Front Line Medical Technologies announced the launch in the United Kingdom of its CE Mark-approved COBRA-OS—Control of Bl ...

Venova Medical recently announced the enrollment of the first patients in the company’s VENOS-2 early feasibility study o ...

Dr. Suresh Vedantham asks Drs. Pavan Kavali and Kristen Sanfilippo about possible benefits of a DVT response team model, ...

Alan Lumsden, MD Walter W. Fondren III Presidential Distinguished Chair, DeBakey Heart & Vascular Center Chair, Department of ...

The VIVA Foundation, in collaboration with representatives from the American Venous Forum (AVF) and American Vein and ...

Moderator Suresh Vedantham, MD, asks Leslie Lake, Volunteer President of the National Blood Clot Alliance and bilateral PE ...

In a large, real-world analysis of United States Medicare fee-for-service patients, Ferro et al found that inferior vena cava ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, ...

The knowns and unknowns about venous thrombus biology as it relates to in-stent restenosis and how these results drive ...

Insights into the digital tools that can help improve patient engagement and advance understanding in deep vein thrombosis ...

Dr. Dorsey discusses her new role as At-Large Executive Board Member of the SVS, her "intentional” style of mentorship, ...

Gore & Associates announced the recent CE Mark approval of a lower-profile Gore Viabahn VBX balloon expandable endoprosthes ...